These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Synthesis of new chalcone derivatives containing acridinyl moiety with potential antimalarial activity. Tomar V, Bhattacharjee G, Kamaluddin, Rajakumar S, Srivastava K, Puri SK. Eur J Med Chem; 2010 Feb; 45(2):745-51. PubMed ID: 20022412 [Abstract] [Full Text] [Related]
9. Theoretical study of the full reaction mechanism of human soluble epoxide hydrolase. Hopmann KH, Himo F. Chemistry; 2006 Sep 06; 12(26):6898-909. PubMed ID: 16856182 [Abstract] [Full Text] [Related]
10. Inhibition of cytosolic epoxide hydrolase by trans-3-phenylglycidols. Dietze EC, Kuwano E, Casas J, Hammock BD. Biochem Pharmacol; 1991 Aug 22; 42(6):1163-75. PubMed ID: 1888328 [Abstract] [Full Text] [Related]
11. Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase. Taylor SJ, Soleymanzadeh F, Eldrup AB, Farrow NA, Muegge I, Kukulka A, Kabcenell AK, De Lombaert S. Bioorg Med Chem Lett; 2009 Oct 15; 19(20):5864-8. PubMed ID: 19758802 [Abstract] [Full Text] [Related]
13. Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N'-diaryl urea inhibitors of soluble epoxide hydrolase. Anandan SK, Gless RD. Bioorg Med Chem Lett; 2010 May 01; 20(9):2740-4. PubMed ID: 20363133 [Abstract] [Full Text] [Related]
14. In vitro metabolism of the mammalian soluble epoxide hydrolase inhibitor, 1-cyclohexyl-3-dodecyl-urea. Watanabe T, Morisseau C, Newman JW, Hammock BD. Drug Metab Dispos; 2003 Jul 01; 31(7):846-53. PubMed ID: 12814960 [Abstract] [Full Text] [Related]
15. Effects of human soluble epoxide hydrolase polymorphisms on isoprenoid phosphate hydrolysis. Enayetallah AE, Grant DF. Biochem Biophys Res Commun; 2006 Mar 03; 341(1):254-60. PubMed ID: 16414022 [Abstract] [Full Text] [Related]
16. Inhibition of soluble epoxide hydrolase by extracts derived from inflammation-treating Chinese medicinal herbs. Shi DH, Xu C, Guo BX, Wang XT, Chen YX, Tan RX. Phytother Res; 2008 Sep 03; 22(9):1264-8. PubMed ID: 18729246 [Abstract] [Full Text] [Related]
18. Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase. Eldrup AB, Soleymanzadeh F, Taylor SJ, Muegge I, Farrow NA, Joseph D, McKellop K, Man CC, Kukulka A, De Lombaert S. J Med Chem; 2009 Oct 08; 52(19):5880-95. PubMed ID: 19746975 [Abstract] [Full Text] [Related]
19. Molecular modelling of human microsomal epoxide hydrolase (EH) by homology with a fungal (Aspergillus niger) EH crystal structure of 1.8 A resolution: structure-activity relationships in epoxides inhibiting EH activity. Lewis DF, Lake BG, Bird MG. Toxicol In Vitro; 2005 Jun 08; 19(4):517-22. PubMed ID: 15826809 [Abstract] [Full Text] [Related]
20. Benzil, a potent activator of microsomal epoxide hydrolase in vitro. Seidegård J, DePierre JW. Eur J Biochem; 1980 Dec 08; 112(3):643-8. PubMed ID: 7460941 [Abstract] [Full Text] [Related] Page: [Next] [New Search]